Maurizio Biagioli
Overview
Explore the profile of Maurizio Biagioli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
552
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Giacomo A, Calabro L, Danielli R, Fonsatti E, Bertocci E, Pesce I, et al.
Cancer Immunol Immunother
. 2013 Apr;
62(6):1021-8.
PMID: 23591982
Background: Ipilimumab can result in durable clinical responses among patients with advanced melanoma. However, no predictive marker of clinical activity has yet been identified. We provide preliminary data describing the...
2.
Rubegni P, Rossi S, Nami N, Risulo M, Biagioli M, Miracco C, et al.
Australas J Dermatol
. 2012 Feb;
53(1):32-6.
PMID: 22309328
Background/objectives: Melanoma has become a major public health problem worldwide and its incidence in individuals of Caucasian origin continues to rise. The objective was to determine historical changes in thickness,...
3.
Di Giacomo A, Danielli R, Calabro L, Bertocci E, Nannicini C, Giannarelli D, et al.
Cancer Immunol Immunother
. 2010 Dec;
60(4):467-77.
PMID: 21170646
Aim Of Study: To evaluate the feasibility of ipilimumab treatment for metastatic melanoma outside the boundaries of clinical trials, in a setting similar to that of daily practice. Methods: Ipilimumab...
4.
Di Giacomo A, Biagioli M, Maio M
Semin Oncol
. 2010 Nov;
37(5):499-507.
PMID: 21074065
The promising new class of immunomodulating antibodies directed against cytotoxic T-lymphocyte antigen-4 (CTLA-4) has been extensively tested in clinical trials and found to be active against cutaneous melanoma and other...
5.
Rubegni P, Cevenini G, Burroni M, Bono R, Sbano P, Biagioli M, et al.
Arch Dermatol Res
. 2010 Apr;
302(7):551-60.
PMID: 20411393
Various authors have suggested that information from longitudinal observation (follow-up) of dynamic changes in atypical melanocytic pigmented skin lesions (MPSL) could enable identification of early malignant melanoma escaping initial observation...
6.
Massi D, Landriscina M, Piscazzi A, Cosci E, Kirov A, Paglierani M, et al.
Mod Pathol
. 2010 Mar;
23(6):804-13.
PMID: 20208480
Angiogenesis is critical in melanoma progression and metastasis and relies on the synthesis and release of proangiogenic molecules such as vascular endothelial growth factor (VEGF)-A and fibroblast growth factors (FGFs)....
7.
Miracco C, Cevenini G, Franchi A, Luzi P, Cosci E, Mourmouras V, et al.
Hum Pathol
. 2009 Dec;
41(4):503-12.
PMID: 20004946
Beclin 1 and LC3 autophagic genes are altered in several human cancer types. This study was designed to assess the expression of Beclin 1 and LC3 in cutaneous melanocytic lesions,...
8.
Rubegni P, Mandato F, Biagioli M, Fimiani M
Australas J Dermatol
. 2009 Aug;
50(3):223-4.
PMID: 19659990
No abstract available.
9.
Mourmouras V, Cevenini G, Cosci E, Epistolato M, Biagioli M, Barbagli L, et al.
J Cutan Pathol
. 2009 Jun;
36(6):637-46.
PMID: 19515042
Background: Nucleolin is a major nucleolar argyrophilic protein involved in carcinogenesis. There are only few studies on its tissue expression in human cancer and none in melanoma. We aimed at...
10.
Cantarini L, Fanti F, Galeazzi M, Martino S, Miracco C, Biagioli M, et al.
Rheumatol Int
. 2009 Jun;
30(6):797-9.
PMID: 19506878
Weber-Christian Disease (WCD), also known as relapsing febrile lobular non-suppurative panniculitis, is a rare condition characterized by recurrent subcutaneous inflammatory nodules in the adipose tissue in addition to fever, malaise...